(Q37822307)

23 August 2017

1 reference

title

Ginkgo biloba in Alzheimer's disease: a systematic review (English)

1 reference

23 August 2017

0 references

0 references

1 reference

Inger M Janssen

1

1 reference

23 August 2017

Sibylle Sturtz

2

1 reference

23 August 2017

Guido Skipka

3

1 reference

23 August 2017

Annette Zentner

4

1 reference

23 August 2017

Marcial Velasco Garrido

5

1 reference

23 August 2017

Reinhard Busse

6

1 reference

23 August 2017

publication date

1 December 2010

1 reference

Wiener Medizinische Wochenschrift

23 August 2017

published in

1 reference

23 August 2017

volume

160

1 reference

23 August 2017

issue

21-22

1 reference

23 August 2017

page(s)

539-546

1 reference

https://scigraph.springernature.com/pub.10.1007/s10354-010-0844-8

23 August 2017

exact match

0 references

cites work

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Complementary and alternative medicines in the treatment of dementia: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Mixed dementia: emerging concepts and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Complementary medicines in psychiatry: review of effectiveness and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Effects of Ginkgo biloba in dementia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-010-0844-8

Ginkgo biloba for cognitive impairment and dementia.

21 January 2018

1 reference

12 December 2020

Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial

1 reference

12 December 2020

Alzheimer's disease therapy--theory and practice

1 reference

12 December 2020

Ginkgo biloba for cognitive impairment and dementia

1 reference

12 December 2020

10.1007/S10354-010-0844-8

Identifiers

DOI

1 reference

23 August 2017

1 reference